CONMED Corporation (CNMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CNMD Revenue Growth
Revenue Breakdown (FY 2025)
CNMD's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CNMD Revenue Analysis (2014–2025)
As of May 7, 2026, CONMED Corporation (CNMD) generated trailing twelve-month (TTM) revenue of $1.37 billion, reflecting slight decline in growth of -0.7% year-over-year. The most recent quarter (Q1 2026) recorded $317.0 million in revenue, down 15.1% sequentially.
Looking at the longer-term picture, CNMD's 5-year compound annual growth rate (CAGR) stands at +9.8%, indicating steady revenue expansion. The company achieved its highest annual revenue of $1.37 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows CNMD's business is primarily driven by General Surgery (58%), and Orthopedic Surgery (42%). With over half of revenue concentrated in General Surgery, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HOLX (+2.2% YoY), ATRC (+15.0% YoY), and NVCR (+8.5% YoY), CNMD has underperformed the peer group in terms of revenue growth. Compare CNMD vs HOLX →
CNMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CNMDCurrent | $1.4B | -0.7% | +9.8% | 10.3% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% | |
 LMAT | $250M | +13.3% | +14.0% | 27.2% |
CNMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.37B | +5.2% | $725.4M | 52.8% | $141.1M | 10.3% |
| 2024 | $1.31B | +5.0% | $733.0M | 56.1% | $200.3M | 15.3% |
| 2023 | $1.24B | +19.1% | $676.2M | 54.3% | $120.6M | 9.7% |
| 2022 | $1.05B | +3.4% | $571.2M | 54.6% | $70.1M | 6.7% |
| 2021 | $1.01B | +17.2% | $568.0M | 56.2% | $109.7M | 10.9% |
| 2020 | $862.5M | -9.7% | $460.3M | 53.4% | $46.0M | 5.3% |
| 2019 | $955.1M | +11.1% | $524.7M | 54.9% | $79.1M | 8.3% |
| 2018 | $859.6M | +7.9% | $469.1M | 54.6% | $71.3M | 8.3% |
| 2017 | $796.4M | +4.3% | $431.0M | 54.1% | $46.9M | 5.9% |
| 2016 | $763.5M | +6.2% | $408.3M | 53.5% | $37.7M | 4.9% |
See CNMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CNMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CNMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCNMD — Frequently Asked Questions
Quick answers to the most common questions about buying CNMD stock.
Is CNMD's revenue growth accelerating or slowing?
CNMD revenue growth slowed to -0.7%, below the 5-year CAGR of +9.8%. TTM revenue is $1.4B. The deceleration marks a shift from historical growth rates.
What is CNMD's long-term revenue growth rate?
CONMED Corporation's 5-year revenue CAGR of +9.8% reflects the variable expansion pattern. Current YoY growth of -0.7% is near this long-term average.
How is CNMD's revenue distributed by segment?
CNMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.